Envista Holdings Corp (NVST)

USD 18.2

(-5.41%)

Gross Profit Summary of Envista Holdings Corp

  • Envista Holdings Corp's latest annual gross profit in 2023 was 1.45 Billion USD , down -2.33% from previous year.
  • Envista Holdings Corp's latest quarterly gross profit in 2024 Q3 was 317.3 Million USD , down -3.82% from previous quarter.
  • Envista Holdings Corp reported a annual gross profit of 1.47 Billion USD in annual gross profit 2022, up 3.39% from previous year.
  • Envista Holdings Corp reported a annual gross profit of 1.42 Billion USD in annual gross profit 2021, up 23.18% from previous year.
  • Envista Holdings Corp reported a quarterly gross profit of 329.9 Million USD for 2024 Q2, down -7.85% from previous quarter.
  • Envista Holdings Corp reported a quarterly gross profit of 317.3 Million USD for 2024 Q3, down -3.82% from previous quarter.

Annual Gross Profit Chart of Envista Holdings Corp (2023 - 2016)

Historical Annual Gross Profit of Envista Holdings Corp (2023 - 2016)

Year Gross Profit Gross Profit Growth
2023 1.45 Billion USD -2.33%
2022 1.47 Billion USD 3.39%
2021 1.42 Billion USD 23.18%
2020 1.15 Billion USD -23.46%
2019 1.51 Billion USD -5.54%
2018 1.6 Billion USD -1.2%
2017 1.62 Billion USD 1.26%
2016 1.6 Billion USD 0.0%

Peer Gross Profit Comparison of Envista Holdings Corp

Name Gross Profit Gross Profit Difference
Alcon Inc. 5.6 Billion USD 74.135%
AptarGroup, Inc. 1.26 Billion USD -14.809%
Baxter International Inc. 4.97 Billion USD 70.844%
Becton, Dickinson and Company 9.15 Billion USD 84.153%
Bausch + Lomb Corporation 2.5 Billion USD 42.073%
Haemonetics Corporation 676.53 Million USD -114.401%
ResMed Inc. 2.6 Billion USD 44.399%
Teleflex Incorporated 1.64 Billion USD 11.927%
Warby Parker Inc. 365.22 Million USD -297.154%
West Pharmaceutical Services, Inc. 1.12 Billion USD -28.454%